Ignite Creation Date:
2024-05-06 @ 1:35 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04065399
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2019-08-16
Brief Title:
A Study of Revumenib in RR Leukemias Including Those With an MLLKMT2A Gene Rearrangement or NPM1 Mutation
Sponsor:
Syndax Pharmaceuticals
Organization:
Syndax Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-16
First Submit QC Date:
August 20 2019
Study First Post Date:
2019-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-11
Last Update Post Date:
2024-05-17
Last Update Post Date Type:
ACTUAL